Unit 11: Drugs that affect the CNS - PowerPoint PPT Presentation

1 / 78
About This Presentation
Title:

Unit 11: Drugs that affect the CNS

Description:

Nancy Pares, RN, MSN NURS 1950 Metropolitan Community College ... – PowerPoint PPT presentation

Number of Views:251
Avg rating:3.0/5.0
Slides: 79
Provided by: ITS51
Category:
Tags: cns | abuse | affect | drugs | unit

less

Transcript and Presenter's Notes

Title: Unit 11: Drugs that affect the CNS


1
Unit 11 Drugs that affect the CNS
  • Nancy Pares, RN, MSN
  • NURS 1950
  • Metropolitan Community College

2
Obj. 1 Describe the general cause of seizures
and the two major clinical findings associated
with seizures.
  • Seizures
  • Abnormal or uncontrolled neuronal discharges in
    the brain
  • affect
  • Consciousness
  • Motor activity
  • Sensation
  • Symptom of an underlying disorder-not a disease
    itself

3
Obj 2 Factors that precipitate seizures
  • Infectious diseases
  • Trauma
  • Metabolic disorders
  • Vascular diseases
  • Pediatric disorders
  • Neoplastic diseases

4
Different etiologies of seizure activity
  • Most common serious neurologic problem affecting
    children
  • May present as an acute situation, or they may
    occur on a chronic basis

5
  • Figure 15.1 EEG recordings showing the
    differences between normal, absence seizure, and
    generalized tonicclonic seizure tracings

6
Drugs as cause of seizures
  • High dose of local anesthetics
  • Drug abuse
  • Withdrawal from alcohol
  • Withdrawal from sedative-hypnotics

7
Convulsion
  • Involuntary violent spasm of large muscles of the
    face, neck, arms and legs
  • Not synonymous with seizure

8
Obj. 3 Name and describe major types of
epileptic seizures
  • Signs and symptoms
  • Related to the area of the brain with abnormal
    activity
  • Types-based on International Classification
  • Partial (focal)
  • Generalized
  • Special epileptic syndromes

9
Simple partial (focal) seizures
  • Occur in limited portion of brain
  • Point of origin abnormal focus or foci
  • Clients experience
  • Feeling that is vague
  • Hallucinations with all senses
  • Extreme emotions
  • Twitching of arms, legs or face

10
Complex partial (focal) seizures
  • Altered levels of consciousness
  • Involve sensory, motor, autonomic symptoms
  • Aura commonly precedes seizure
  • No memory of seizure

11
Generalized seizures
  • Travel throughout the entire brain
  • Subcatagories
  • Absence
  • Atonic
  • Tonic-clonic

12
Absence seizures
  • Common in children
  • Subtle symptoms
  • Staring
  • Transient loss of consciousness
  • Eyelid fluttering
  • Myclonic jerks

13
Atonic seizures
  • Usually last only a few seconds
  • Characterized by stumbling or falling

14
Tonic clonic
  • Most common
  • Usually preceded by aura
  • Tonic phase
  • Intense muscle contractions
  • Hoarse cry at onset
  • Loss of bowel/bladder control
  • Shallow breathing

15
Tonic clonic, cont
  • Clonic phase
  • Alternating contraction and relaxation of muscles
  • Postictal state (post seizure)
  • Drowsiness, disorientation, deep sleep

16
Special epileptic syndromes
  • Febrile seizures
  • Myoclonic seizures
  • Status epilepticus

17
Febrile seizures
  • Last one two minutes
  • Tonic clonic motor activity
  • Common in 3-5 year olds
  • Occur with rapid rise in body temperature
  • Affect 5 of all children

18
Myoclonic seizures
  • Large jerking body movements
  • Quick contraction of major muscles
  • Stumbling and falling
  • Similar to normal infantile Moro reflex

19
Status epilepticus
  • Medical emergency
  • Continuously repeating seizure
  • Common with generalized tonic-clonic
  • Continuous muscle contractions
  • May compromise airway
  • May cause hypoglycemia, hypothermia, acidosis
  • May produce lactic acid

20
Obj. 4, 5, 6,and 7 (inclusive)
  • The choice of drug depends upon
  • Type of seizure
  • Client history and diagnostic studies
  • Pathologic process causing seizures

21
Once Medication is Selected
  • Patient placed on low initial dose
  • Amount gradually increased
  • If seizure activity remains, different medication
    added in small increments
  • Newer antiseizure drugs have less adverse side
    effects than older drugs
  • Most cases require only a single drug

22
(No Transcript)
23
New FDA Warnings
  • Study included patients with epilepsy, bipolar
    disorder, psychoses, migraines, and neuropathic
    pain
  • Popular antiseizure examples found to almost
    double risk of suicidal behavior and ideation

24
Antiseizure Pharmacotherapy
  • Goal suppress neuronal activity enough to
    prevent abnormal or repetitive firing
  • Drugs act through three mechanisms
  • Stimulating an influx of chloride ions
  • Delaying an influx of sodium
  • Delaying an influx of calcium

25
Antiseizure Pharmacotherapy (cont'd)
  • Directed at controlling movement of electrolytes
    across neuronal membranes or affecting
    neurotransmitter balance
  • Some drugs act by more than one mechanism

26
Pharmacotherapy Illustrated Model of the GABA
ReceptorChloride Channel Molecules in
Relationship to Antiseizure Pharmacotherapy
27
Barbiturates and GABA Agents
  • GABA gamma aminobutyric acid
  • Primary neuro transmitter of brain.
  • Drugs that potentiate GABA action
  • Barbiturates
  • Benzodiazepines
  • Misc. agents

28
Barbiturates
  • Prototype phenobarbital (Luminal)
  • Mechanism of action
  • Changing the action of GABA
  • Primary use
  • Controlling seizures
  • Adverse effects
  • Dependence, drowsiness, vitamin deficiencies,
    laryngeospasm

29
Benzodiazepines
  • Prototype diazepam (Valium)
  • Mechanism of action
  • Similar to barbiturates, but safer
  • Primary use
  • Short term seizure control
  • Adverse effects
  • Drowsiness and dizziness

30
Miscellaneous GABA Agents
  • Prototype valproic acid (Depakene)
  • Mechanism of action
  • similar to benzos and barbiturates
  • Primary use
  • Adjunct therapy
  • Adverse effects
  • Sedation, drowsiness, GI upset, prolonged
    bleeding time

31
Hydantoins
  • Prototype phenytoin (Dilantin)
  • Mechanism of action
  • Desensitize sodium channel blockers
  • Primary use
  • Treatment of all types of seizures, except
    absence seizures
  • Adverse effects
  • CNS depression, gingival hyperplasia, skin rash,
    cardiact dysrhythmias, and hypotension

32
Phenytoin-like Drugs
  • Prototype drug valproic acid (Depakene)
  • Mechanism of action
  • Desensitize sodium channels
  • Primary use
  • Absence seizures
  • Adverse effects
  • Limited CNS depression, visual disturbances,
    ataxia, vertigo, HA, GI, hepatotoxicity,
    pancreatitis

33
Succinimides
  • Prototype ethosuximide (Zarontin)
  • Mechanism of action
  • Suppress calcium influx
  • Primary use
  • Absence seizures
  • Adverse effects
  • Rare, but include drowsiness, dizziness, lethargy
  • Rare, but serious lupus, leukopenia, aplastic
    anemia, Stevens-Johnson syndrome

34
Nurses role in pharmacological management
  • Barbiturates
  • Monitor for liver and kidney function
  • Category D in pregnancy
  • Depletion of nutrients
  • Alcohol and ginko biloba interactions
  • Client teaching
  • Use reliable contraception
  • Immediately report pregnancy
  • Report excessive bleeding,drowsiness, bone pain
  • Avoid alcohol and gingko biloba

35
Benzodiazepines-schedule IV drug
  • Monitor for drug abuse potential
  • Pregnancy risk (category D)
  • Contraindicated in narrow angle glaucoma
  • Liver and kidney function monitored
  • Respiratory depression
  • In event of overdose
  • Give flumazenil (Romazicon)

36
Status epilepticus
  • Give IV valium and ativan
  • Do not mix with other drugs in IV line
  • Client teaching
  • Avoid ETOH, OTC drugs, herbal preps, nicotine,
    driving and hazardous activities
  • Rebound seizures if d/c abruptly
  • Take with food
  • These drugs most often used illegally

37
Hydantoin and Phenytoin-like drugs
  • Monitor serum drug levels, liver and kidney
    function
  • Monitor for bleeding disorders
  • Fatal hepatotoxicity can occur
  • Contraindicated
  • Hx of heart block or seizures due to low BS
  • Client teaching
  • Routine labs report s/s of toxicity, bleeding,
    pregnancy, hypoglycemia

38
Succinimides
  • Monitor for liver and kidney function
  • Pregnancy category C
  • Adverse reactions
  • Drowsiness, HA, euphoria, n/v, weight loss, abd.
    Pain
  • Life threatening reactions
  • Mental depression with suicide intent
  • Blood dyscrasias and Stevens-Johnson syndrome

39
Succinimides
  • Symptoms of overdose
  • CNS depression, stupor, ataxia, coma
  • Client teaching
  • Report mood changes or suicidal thoughts
  • Avoid driving and hazardous activities
  • Take with food
  • Do not stop abruptly
  • Report weight loss and anorexia

40
General client teachings for epilepsy
  • Start with smallest dose of med
  • Add additional drugs, if needed
  • Monitor serum drug levels
  • Withdrawal of meds
  • Seizure free for three years
  • Done gradually
  • Resume meds if seizures return
  • Knowledge of rebound seizures

41
Nursing diagnosis for epilepsy
  • Disturbed sensory perception RT seizure activity
  • Risk for injury RT seizure activity
  • Deficient knowledge RT disease/drugs
  • Noncompliance RT drug regime
  • Noncompliance RT serum lab testing

42
Goals in epilepsy treatment
  • Absence/reduction in number of seizures
  • No injury during seizure
  • Understanding of disease
  • Understanding of drug regimen
  • Compliance with lab testing

43
  • Objective 8 Describe common symptoms of
    Parkinsons Disease.
  • Objective 9 Describe the role of dopamine in
    the body.
  • Objective 10 name the preparations used to
    treat Parkinsons.

44
  • Objective 11 describe the role of the
    anticholinergic drugs in the treatment of
    Parkinsons
  • Objective 12 Apply nursing process as it relates
    to the care of the client with Parkinsons and
    accompanying drug therapy.

45
Parkinsons Disease
  • Second most common CNS disease
  • Progressive loss of dopamine
  • Tremor, muscle rigidity
  • Abnormal movement and posture

46
(No Transcript)
47
Symptoms of Parkinsons Disease
  • Symptoms known as parkinsonism
  • Tremors
  • Muscle rigidity
  • Bradykinesia
  • Postural instability
  • Affective flattening

48
Health Problems in Parkinsons Patients
  • Primarily affects muscle movement
  • Patients often experience other health issues
  • Anxiety, depression
  • Sleep disturbances
  • Dementia
  • Autonomic nervous system disturbances

49
Cause of Symptoms
  • Degeneration and destruction of
    dopamine-producing neurons
  • Substantia nigra portion of brain
  • Corpus striatum
  • Normally controls unconsciousness muscle movement

50
Neurotransmitters
  • Dopamine and acetylcholine in corpus striatum
  • Affect balance, posture
  • Affect muscle tone, involuntary movement
  • Absence of dopamine
  • Allows acetylcholine stimulation

51
Drug Therapy for Parkinsonism
  • Restores dopamine function
  • Blocks acetylcholine
  • Extrapyramidal side effects (EPS)

52
(No Transcript)
53
Antiparkinsonism Agents
  • Restore balance of dopamine and acetylcholine in
    brain
  • Dopaminergic drugs
  • Dopaminergic adjunct agents
  • Anticholinergics (cholinergic blockers)

54
Dopaminergics
  • Restore balance of dopamine and acetylcholine
  • Dopaminergic examples
  • Levodopa (Larodopa),
  • Levodopa and carbidopa (Sinemet)

55
Levodopa (Larodopa)
  • Levodopa (Larodopa) is drug of choice
  • Increases biosynthesis of dopamine within nerve
    terminals
  • Effectiveness boosted by combining with carbidopa
    (Sinemet)

56
Dopaminergic Adjunct Agents
  • Inhibit enzymes
  • Example Tolcapone (Tasmar)
  • Activate dopamine receptors (dopamine agonists)
  • Example Ropinirole (Requip)
  • Cause dopamine release from nerve terminals
  • Example Amantadine (Symmetrel)

57
Anticholinergic Agents
  • Centrally acting
  • Block acetylcholine
  • Inhibits overactivity in brain
  • Used in early stages
  • Examples
  • Benztropine mesylate (Cogentin)
  • Triexyphenidyl hydrochloride (Artane)

58
Catechol-O-Methyl Transferase (COMT) Inhibitors
  • Reduce requirement for L-dopa
  • Increase concentration of existing dopamine
    improve motor fluctuations
  • Examples
  • entacapone (Comtan)
  • tolcapone (Tasmar)

59
Dopaminergic Agents
  • Prototype drug levodopa (Larodopa)
  • Mechanism of action Increases biosynthesis of
    dopamine within nerve terminals
  • Primary use to restore dopamine function or
    stimulate dopamine receptors within the brain

60
Dopaminergic Agents (continued)
  • Adverse effects dizziness, light-headedness,
    sleep dysfunction, fatigue, nausea, vomiting,
    constipation, orthostatic hypertension, dystonia,
    dyskinesia

61
(No Transcript)
62
(No Transcript)
63
Levadopa Animation
  • Click here to view an animation on the topic of
    levadopa.

64
Anticholinergic Agents
  • Prototype drug benztropine mesylate (Cogentin)
  • Mechanism of action block acetylcholine inhibit
    overactivity in brain
  • Primary use in early stages of disease
  • Adverse effects dry mouth, blurred vision,
    photophobia, urinary retention, constipation,
    tachycardia, glaucoma

65
(No Transcript)
66
(No Transcript)
67
Role of the Nurse Dopaminergic Drug Therapy
  • Contraindicated in narrow-angle glaucoma
  • Monitor for hypotension and tachycardia
  • Look for symptoms of drug toxicity

68
Dopaminergics Client Teaching
  • Increase fiber and fluids
  • Avoid food and drugs high in pyridoxine
  • May take several months for full effect
  • Abruptly stopping the drug may cause Parkinsonism
    crisis

69
Anticholinergics Client Teaching
  • Relieve dry mouth with frequent drinks or
    sugarless hard candy
  • Take with food or milk to prevent GI upset
  • Avoid alcohol
  • Wear dark glasses avoid bright sunlight
  • Do not stop taking abruptly

70
Nursing Considerations with AChE Inhibitors
  • Assess baseline vitals
  • Monitor for hypotension
  • Monitor for change in mental status or mood
  • Monitor for dizziness, insomnia, anorexia
  • Clients with narrow-angle glaucoma should not
    take revastigmine (Exelon)

71
Obj. 13 define sedative and hypnotic
  • Sedative
  • An agent that calms nervousness, irritability and
    excitement
  • Hypnotic
  • An agent that induces sleep

72
  • Objective 14 describe actions, use and s/e of
    barbiturates (covered earlier)
  • Objective 15 identify the commonly used
    barbiturates and benzo (covered earlier)

73
Obj. 16 Name the conditions that may cause
muscle spasticity.
  • Results from damage to the motor area of the
    cerebral cortex
  • Conditions
  • Cerebral palsy
  • severe head injury, spinal cord injury or
    lesions
  • stroke
  • dystonia

74
Obj. 17 Goals of drug therapy for muscle spasms
  • Goals of muscle relaxants
  • Minimize discomfort
  • Increase ROM
  • Improve ability to function independently

75
Obj. 18 Name the musculoskeletal relaxants
  • Centrally acting muscle relaxants
  • Prototype cyclobenzaprine (Flexeril)
  • Mechanism of action
  • Inhibits upper motor neuron activity
  • Alters simple spinal reflexes, causes CNS
    depression
  • Primary Use
  • Treat localized spasms
  • Adverse effects
  • CNS depression, hepatic toxicity, physical
    dependence, anticholinergic effects

76
Obj. 18 cont
  • Direct acting antispasmodics
  • Prototype dantrolene (Danantrium)
  • Mechanism of action
  • Interferes with release of calcium ions in
    skeletal muscle
  • Primary use
  • Relieve dystonias and leg cramps
  • Adverse effects
  • Hepatic toxicity, muscle weakness, drowsiness,
    diarrhea

77
Obj. 19 Nursing process for CNS drugs
  • Assessment
  • Monitor pain, LOC, vital signs
  • Monitor muscle tone, ROM, degree of spasms
  • Monitor labs
  • Nursing Dx
  • Pain
  • Impaired physical mobility
  • Risk for injury
  • Deficient knowledge

78
Obj. 19 cont
  • Goals
  • Decrease pain
  • Increase range of motion (ROM)
  • Reduce muscle spasms
  • No adverse effects of drugs
  • Knowledge of drug regimen
Write a Comment
User Comments (0)
About PowerShow.com